Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234096 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
The results of this study have identified the combined profile FGF-2/β3 integrin expression as a signature of local control in patients treated with chemoradiotherapy for locally advanced NSCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Carole M.D., Isabelle M.D., Valérie M.D., Julien M.D., Ph.D., Jean-Marc M.D., Jean-Pierre M.D., Marie-Bernadette M.D., Gilles Ph.D., Christine Ph.D., Elizabeth M.D., PhD.,